ZURICH, July 1, 2015 /PRNewswire/ --
The Haselmeier Group has decided to reinforce and reorganise its Executive Board. Mr. Gert Weber has been nominated by the Board of Directors of Medico Invest AG as Chief Executive Officer (CEO) of the Haselmeier Group. This nomination is effective starting July 1st, 2015. Mr. Weber brings more than 20 years of experience in the manufacturing and technological industries and has filled various executive management positions, the last being Managing Director and Vice President responsible for Operations and Information Technology (IT) at Avnet TS (former Magirus Group). With his experience and expertise, Mr. Weber shall contribute to strengthen Haselmeier's position and performance in the medical device industry and beyond.
Mr. Weber has joined Haselmeier as Chief Information Officer (CIO) on May 1st, 2015, and will continue to lead Haselmeier's efforts to build up efficient organization and a state-of-the-art IT. Haselmeier is committed to position IT as a strategic growth driver for its operations as well as an opportunity to develop new business areas.
Mr. Andreas Schieber leaves Haselmeier, starting June 30th, 2015. Mr. Schieber has - as interim Chairman of the Executive Board - actively contributed to the structuring and installation of Haselmeier's Group Management.
Furthermore Haselmeier offers more clarity to its Quality Organisation and establishes two subgroups covering respectively Quality Management and Quality Assurance, with dedicated teams and leadership. Both groups will report into Mr. Matthias Meissner who has endorsed the function of Chief Quality Officer (CQO), effective since July 1st, 2015 and on an interim basis. Mr. Meissner replaces Mr. Markus Dorsch who contributed to build Haselmeier's Quality Management over the past ten years. Mr. Meissner has been very instrumental in the development of Haselmeier's infrastructure and the installation of efficient manufacturing capabilities and shall support the installation of a global Quality Management.
Mr. Siegfried Eichinger has been appointed Chief Financial Officer (CFO), effective since July 1st, 2015. In his extended CFO role, Mr. Eichinger will lead Haselmeier's global finance and controlling and will be responsible for the Group's Human Resources Management. Mr. Eichinger brings more than 20 years of experience in the technological and healthcare industries and shall ensure Haselmeier a sound and coordinated planning, development and management of its resources on a group-wide basis.
With the reinforcement of its Executive Board, Haselmeier demonstrates its commitment for a sustainable development towards high performance, breakthrough innovations and excellent service for its customers.
Founded in Stuttgart in 1920, Haselmeier is a global medical device company and a leading designer and manufacturer of pen and auto injection systems. The devices feature unique function, design and technology and are marketed by leading pharmaceutical and biotechnology companies around the world. Located in five locations across three continents, we develop and produce innovative technologies for administering medication to improve the health and everyday life of patients.
For more information please visit http://www.haselmeier.com
Nadia Di Secli
SOURCE Haselmeier AG